* From 2023 on, called "Biopharma" ("Pharmaceuticals" + "Vaccines").
** During 2016, the Animal Health and the Consumer Healthcare segments were the objects of a swap deal between Sanofi and Boehringer Ingelheim. Since 2016, Animal Health revenues were no longer part of Sanofi's total revenues.
*** For 2024, the ongoing separation process of the consumer healthcare segment (Opella) is already classified as discontinued operation, and thus not included.
In 2025, French pharmaceutical company Sanofi generated over ** billion euros through its biopharmaceutical segment. In 2023, Sanofi’s consumer healthcare segment earned the company about *** billion euros in that year. As of early 2025, due to several restructuring measures, Sanofi consists only of the biopharma segment.
Sanofi’s top products
Sanofi develops various pharmaceutical products, including Dupixent and Lantus. Lantus has been one of the company’s top products for many years. In 2024, this long-acting insulin, used to treat diabetes, generated some *** billion euros.
Top U.S. drugs
Based on sales numbers over the last years, Humira is by far the top prescription drug in the United States. Before 2023, the drug generated around ** billion U.S. dollars in the United States per year. Among the country’s most prescribed medicines, however, are atorvastatin, lisinopril, and levothyroxine.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Sanofi, & Company filings. (February 17, 2026). Revenue of Sanofi by segment from 2014 to 2025 (in million euros) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 27, 2026, from /statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi, und Company filings. "Revenue of Sanofi by segment from 2014 to 2025 (in million euros)." Chart. February 17, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 27, 2026. /statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi, Company filings. (2026). Revenue of Sanofi by segment from 2014 to 2025 (in million euros). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 27, 2026. /statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi, and Company filings. "Revenue of Sanofi by Segment from 2014 to 2025 (in Million Euros)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Feb 2026, /statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi & Company filings, Revenue of Sanofi by segment from 2014 to 2025 (in million euros) ÌÇÐÄÆƽâ°æ, /statistics/266504/sanofi-aventis-revenue-by-product/ (last visited July 27, 2026)
Revenue of Sanofi by segment from 2014 to 2025 (in million euros) [Graph], Sanofi, & Company filings, February 17, 2026. [Online]. Available: /statistics/266504/sanofi-aventis-revenue-by-product/
